.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing the risk of placenta accreta spectrum transfusion is a critical priority for obstetricians performing cesarean deliveries. Placenta accreta spectrum (PAS) often involves severe hemorrhage, making it a leading cause of maternal morbidity in India. However, specific indicators to predict the need for intraoperative blood products remain scarce in clinical practice. Consequently, researchers conducted a retrospective study to identify which routinely available clinical and sonographic factors correlate with transfusion requirements.
The study analyzed 312 patients and found that 40% required intraoperative blood products. Notably, an antenatal diagnosis of placenta previa and sonographic suspicion of PAS emerged as the strongest independent predictors. Patients with placenta previa faced a nearly five-fold increase in transfusion risk. Moreover, sonographic suspicion more than tripled the odds of needing a transfusion. These findings demonstrate that clinicians can effectively use these markers during preoperative planning to enhance patient safety. Similarly, identifying these factors early allows for better resource allocation in tertiary centers.
In cases of grade-1 PAS, placenta previa remained the primary predictor of transfusion. Furthermore, the researchers observed that intraoperative factors like hysterectomy and longer operative times were more common among transfused patients. However, these factors typically reflect surgical complexity rather than initial preoperative risk. Therefore, utilizing antenatal ultrasound and clinical history is essential for pragmatic surgical preparation. Additionally, a multidisciplinary approach ensures that surgical teams remain prepared for potential hemodynamic instability during delivery.
The primary clinical predictors are an antenatal diagnosis of placenta previa and sonographic suspicion of placenta accreta spectrum. These factors are strongly associated with the increased need for intraoperative blood products.
In grade-1 placenta accreta spectrum, placenta previa acts as the sole independent predictor for blood transfusion. It significantly increases the likelihood of surgical complexity and intraoperative hemorrhage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study identifies placenta previa and ultrasound suspicion as major predictors for intraoperative blood transfusion in placenta accreta spectrum management...
5 months ago
Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today
Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today
Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today
Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today
A Brazilian birth cohort reveals significant sex-specific associations between preterm birth and adolescent adiposity, underscoring the urgent need for targeted long-term cardiometabolic surveillance and tailored clinical monitoring.
Today
